• All sections
  • C - Chemistrymetallurgy
  • C07D - Heterocyclic compounds
  • C07D 233/60 - Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, attached to ring carbon atoms with hydrocarbon radicals, substituted by oxygen or sulfur atoms, attached to ring nitrogen atoms

Patent holdings for IPC class C07D 233/60

Total number of patents in this class: 412

10-year publication summary

21
27
23
27
23
30
17
15
22
5
2017 2018 2019 2020 2021 2022 2023 2024 2025 2026

Principal owners for this class

Owner
All patents
This class
BASF SE
21303
19
Antecip Bioventures II LLC
374
16
Tokyo Ohka Kogyo Co., Ltd.
1562
10
The University of British Columbia
1538
9
Daicel Corporation
2523
8
Cellix Bio Private Limited
52
7
vTv Therapeutics LLC
152
6
Novartis AG
10262
5
FUJIFILM Corporation
30514
5
Agency for Science, Technology and Research
3733
5
British Columbia Cancer Agency Branch
182
5
King Saud University
513
5
Kureha Corporation
1059
5
University of Pittsburgh - Of the Commonwealth System of Higher Education
3304
5
LG Energy Solution, Ltd.
18906
5
Bristol-myers Squibb Company
4742
4
Hoffmann-La Roche Inc.
3793
4
Henkel AG & Co. KGaA
10770
4
UDC Ireland Limited
508
4
The United States Government AS represented by The Department of Veterans Affairs
1329
4
Other owners 277